Monitoring Regular physician check-ins (every 2 to 4 weeks during titration, monthly during maintenance) track GI tolerance, weight loss progress, body composition, energy levels, and any adverse events
Approved GLP-1 Agonists for Weight Loss Currently, there are two GLP-1R agonists approved for the treatment of obesity, Saxenda (liraglutide) and Wegovy (semaglutide) , both developed by Novo Nordisk and approved by the FDA in 2014 and 2021, respectively
But you still want the weight loss results
In some cases, the taste may come and go rather than remain constant
This characteristic allows researchers to work with the compound effectively in a variety of laboratory and preclinical settings
Some people feel unsettled by how quickly their appetite and body change